Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2010-02-11
Original market date: See footnote 1
2010-02-11
Product name:
ORAQIX
Description:
FOR PERIODONTAL USE
DIN:
02325993
Product Monograph/Veterinary Labelling:
Date:
2009-04-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
DENTSPLY CANADA LIMITED
1
525 Rowntree Dairy Road
Woodbridge
Ontario
Canada
L4L 7K6
Class:
Human
Dosage form(s):
Gel
Route(s) of administration:
Topical
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
52:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N01BB20 COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0222447001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| LIDOCAINE | 2.5 % |
| PRILOCAINE | 2.5 % |